A developer of an implanted electric field therapy (EFT) device for brain tumours has been awarded a £1.26m grant under the Biomedical Catalyst programme.  The funding will support key technical and regulatory milestones to prepare for QV Bioelectronics’ (QV) first-in-human trial of GRACE, the first fully implanted EFT system designed to deliver continuous, targeted therapy … Continue reading MedTech wins £1.26m Innovate UK grant to tackle brain tumours